Medical magnetic resonance imaging (MRI) produces high-resolution anatomical images of the human body, but has limited capacity to provide useful molecular information. The light-responsive, liposomal MRI contrast agent described herein could be used to provide an intrinsic theranostic aspect to MRI and enable tracking the distribution and cargo release of drug delivery systems upon light-triggered activation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c9cc05516a | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Light-Responsive Smart Nanoliposomes: Harnessing the Azobenzene Moiety for Controlled Drug Release under Near-Infrared Irradiation.
ACS Appl Mater Interfaces
October 2024
College of Materials Science and Engineering, Zhejiang University of Technology, Huzhou 313000, P.R. China.
The azobenzene moiety is an intriguing structure that deforms under UV and visible light, indicating a high potential for biomedical applications. However, its reaction to UV radiation is problematic because of its high energy and low tissue penetration. Unlike previous research on azobenzene structures in photoresponsive materials, this study presents a novel method for imparting photostimulation-responsive properties to liposomes by incorporating the azobenzene moiety and extending the light wavelength with up-conversion nanoparticles.
View Article and Find Full Text PDFA visible light-activated azo-fluorescent switch for imaging-guided and light-controlled release of antimycotics.
Nat Commun
October 2024
State Key Laboratory of Green Pesticide, International Joint Research Center for Intelligent Biosensor Technology and Health, College of Chemistry, Central China Normal University, Wuhan, PR China.
Article Synopsis
- *When exposed to visible light, the azo switch undergoes isomerization, resulting in fluorescence changes that can be easily observed.
- *The research also shows that nanoparticles containing the azo switch can effectively release antimycotics to kill a specific fungus, Rhizoctonia solani, and have a longer holding period compared to traditional antimycotics, suggesting potential for broader drug delivery applications.
Near-infrared light-responsive hydrogels for on-demand dual delivery of proangiogenic growth factors.
Acta Biomater
July 2024
Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX 78711, United Sates. Electronic address:
Achieving precise spatiotemporal control over the release of proangiogenic factors is crucial for vasculogenesis, the process of de novo blood vessel formation. Although various strategies have been explored, there is still a need to develop cell-laden biomaterials with finely controlled release of proangiogenic factors at specific locations and time points. We report on the developed of a near-infrared (NIR) light-responsive collagen hydrogel comprised of gold nanorods (GNRs)-conjugated liposomes containing proangiogenic growth factors (GFs).
View Article and Find Full Text PDFpH/ Temperature/ Redox and Light-responsive Polymersome Structure and Application in Cancer Therapy: Smart Drug Delivery and Targeted Drug Release.
Curr Med Chem
May 2024
Australasian Nanoscience and Nanotechnology Initiative (ANNI), Monash University LPO, Clayton, VIC 3168, Australia.
Improvements in cancer treatment are largely influenced by more people knowing about it and developing new ways to diagnose and treat it. New methods such as nanotheranostics and the use of tiny particles have greatly improved the diagnosis, control and treatment of cancer. They have also helped overcome problems with traditional treatments.
View Article and Find Full Text PDFLight-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
Molecules
January 2024
Departamento de Investigación en Hiperreactividad Bronquial, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Calzada de Tlalpan 4502, Mexico City 14080, Mexico.
In recent years, nanocarriers have played an ever-increasing role in clinical and biomedical applications owing to their unique physicochemical properties and surface functionalities. Lately, much effort has been directed towards the development of smart, stimuli-responsive nanocarriers that are capable of releasing their cargos in response to specific stimuli. These intelligent-responsive nanocarriers can be further surface-functionalized so as to achieve active tumor targeting in a sequential manner, which can be simply modulated by the stimuli.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!